Bayer AG (LTS:0P6S) Cyclically Adjusted PB Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0P6S Bayer AG LTS:0P6S
55 GF Score
Price €49.89
GF Value €27.20
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bayer AG Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG  (LTS:0P6S) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bayer AG Cyclically Adjusted PB Ratio Related Terms


Bayer AG Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Bayer AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Cyclically Adjusted PB Ratio Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.20 0.79 0.44 0.84

Bayer AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.63 0.84 0.88 1.08

LTS:0P6S vs LLY, JNJ, ABBV: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PB Ratio falls into.


LTS:0P6S
55GF Score
Bayer AG LTS:0P6S
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bayer AG's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Bayer AG's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=30.113/131.3638*131.3638
=30.113

Current CPI (Jun. 2026) = 131.3638.

Bayer AG Quarterly Data

Book Value per Share CPI Adj_Book
201609 27.840 101.017 36.204
201612 36.097 101.217 46.848
201703 40.005 101.417 51.818
201706 38.855 102.117 49.983
201709 44.264 102.717 56.609
201712 43.794 102.617 56.062
201803 43.964 102.917 56.116
201806 50.556 104.017 63.847
201809 53.879 104.718 67.589
201812 49.212 104.217 62.031
201903 51.375 104.217 64.757
201906 45.577 105.718 56.634
201909 46.787 106.018 57.973
201912 48.098 105.818 59.710
202003 49.479 105.718 61.482
202006 36.343 106.618 44.778
202009 31.887 105.818 39.585
202012 31.069 105.518 38.679
202103 35.207 107.518 43.015
202106 30.933 108.486 37.456
202109 31.659 109.435 38.003
202112 33.611 110.384 39.999
202203 38.107 113.968 43.924
202206 38.699 115.760 43.915
202209 42.010 118.818 46.446
202212 39.467 119.345 43.442
202303 41.595 122.402 44.640
202306 37.609 123.140 40.121
202309 33.977 124.195 35.938
202312 33.516 123.773 35.572
202403 36.242 125.038 38.075
202406 36.325 125.882 37.907
202409 31.106 126.198 32.379
202412 32.479 127.041 33.584
202503 33.027 127.779 33.954
202506 30.913 128.412 31.624
202509 30.107 129.255 30.598
202512 26.411 129.361 26.820
202603 29.361 131.258 29.385
202606 30.113 131.364 30.113

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bayer AG (LTS:0P6S) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of €49.89 is trading 83.4% above its estimated GF Value™ of €27.20. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for LTS:0P6S:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €27.20 vs. price of €49.89 (83.4% above fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the LTS:0P6S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
55GF Score

Get the complete analysis for LTS:0P6S

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.89
Price
€27.20
GF Value